HEALTH OF WOMAN. 2019.2(138): 122–128

Погляд комітету експертів Американського коледжу акушерів і гінекологів
Номер 760
Комітет з Охорони здоров’я підлітків
Дана концепція експертів була розроблена Комітетом з Охорони здоров’я підлітків Американського коледжу акушерів і гінекологів у співпраці з членами комітету Geri D. Hewitt, MD та Karen R. Gerancher, MD.
20 листопада 2018 року Dysmenorrhea and endometriosis in the adolescent.
ACOG Committee Opinion No. 760. American College of Obstetricians and Gynecologists.
Obstet Gynecol 2018;132:e249–58.

СПИСОК ЛІТЕРАТУРИ

1. Al-Jefout M, Nawaiseh N. Continuous norethisterone acetate versus cyclical drospirenone 3 mg/ethinyl estradiol 20 mg for the management of primary dysmenorrhea in young adult women. J Pediatr Adolesc Gynecol 2016;29:1437.

2. Gantt PA, McDonough PG. Adolescent dysmenorrhea. Pediatr Clin North Am 1981;28:389–95.

3. Chan WY, Hill JC. Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects. Prostaglandins 1978;15:365–75.

4. Harel Z, Lilly C, Riggs S, Vaz R, Drazen J. Urinary leukotriene (LT) E(4) in adolescents with dysmenorrhea: a pilot study. J Adolesc Health 2000;27:151–4.

5. Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997;10:199–202.

6. Janssen EB, Rijkers ACM, Hoppenbrouwers K, Meuleman C, D’Hooghe TM. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review. Hum Reprod Update 2013;19:570–82.

7. Royal College of Obstetricians and Gynaecologists. The initial management of chronic pelvic pain. Green-top Guideline No. 41. London (UK): RCOG; 2012. Available at: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_41.pdf. Retrieved July 30, 2018.

8. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics 1981;68:661–4.

9. Woosley JA, Lichstein KL. Dysmenorrhea, the menstrual cycle, and sleep. Behav Med 2014;40:14–21.

10. Zannoni L, Giorgi M, Spagnolo E, Montanari G, Villa G, Seracchioli R. Dysmenorrhea, absenteeism from school, and symptoms suspicious for endometriosis in adolescents. J Pediatr Adolesc Gynecol 2014;27:258–65.

11. DiVasta AD, Vitonis AF, Laufer MR, Missmer SA. Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood. Am J Obstet Gynecol 2018;218:324.e1–11.

12. Dun EC, Kho KA, Morozov VV, Kearney S, Zurawin JL, Nezhat CH. Endometriosis in adolescents. JSLS 2015;19(2): e2015.00019.

13. Derman O, Kanbur NO, Tokur TE, Kutluk T. Premenstrual syndrome and associated symptoms in adolescent girls. Eur J Obstet Gynecol Reprod Biol 2004;116:201–6.

14. Kitamura M, Takeda T, Koga S, Nagase S, Yaegashi N. Relationship between premenstrual symptoms and dysmenorrhea in Japanese high school students. Arch Womens Ment Health 2012;15:131–3.

15. Balık G, Ustuner I, Ka_gıtcı M, Sahin FK. Is there a relationship between mood disorders and dysmenorrhea?. J Pediatr Adolesc Gynecol 2014;27:371–4.

16. Nur Azurah AG, Sanci L, Moore E, Grover S. The quality of life of adolescents with menstrual problems. J Pediatr Adolesc Gynecol 2013;26:102–8.

17. Greene R, Stratton P, Cleary SD, Ballweg ML, Sinaii N. Diagnostic experience among 4,334 women reporting surgically diagnosed endometriosis. Fertil Steril 2009;91:32–9.

18. Mann J, Shuster J, Moawad N. Attributes and barriers to care of pelvic pain in university women. J Minim Invasive Gynecol 2013;20:811–8.

19. Boerner KE, Chambers CT, McGrath PJ, LoLordo V, Uher R. The effect of parental modeling on child pain responses: the role of parent and child sex. J Pain 2017;18:702–15.

20. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No.: CD001751.

21. Jung H, Lee J. The effectiveness of an educational intervention on proper analgesic use for dysmenorrhea. Eur J Obstet Gynecol Reprod Biol 2013;170:480–6.

22. Harel Z. Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies. Expert Opin Pharmacother 2012;13:2157–70.

23. Galinkin J, Koh JL. Recognition and management of iatrogenically induced opioid dependence and withdrawal in children. Committee on Drugs, Section on Anesthesiology and Pain Medicine, American Academy of Pediatrics. Pediatrics 2014;133:152–5.

24. Volkow ND, McLellan AT. Opioid abuse in chronic pain—misconceptions and mitigation strategies. N Engl J Med 2016;374:1253–63.

25. Noncontraceptive uses of hormonal contraceptives. Practice Bulletin No. 110. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;115:206–18.

26. Dmitrovic R, Kunselman AR, Legro RS. Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial. Obstet Gynecol 2012;119:1143–50.

27. Laufer MR. Helping “adult gynecologists” diagnose and treat adolescent endometriosis: reflections on my 20 years of personal experience. J Pediatr Adolesc Gynecol 2011;24 (5 suppl):s13–7.

28. Chaudhuri A, Singh A, Dhaliwal L. A randomised controlled trial of exercise and hot water bottle in the management of dysmenorrhoea in school girls of Chandigarh, India. Indian J Physiol Pharmacol 2013;57:114–22.

29. Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, et al. Dietary supplements for dysmenorrhoea. Cochrane Database of Systematic Reviews 2016, Issue 3. Art. No.: CD002124.

30. Bahrami A, Avan A, Sadeghnia HR, Esmaeili H, Tayefi M, Ghasemi F, et al. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol Endocrinol 2018;34:659–63.

31. Proctor M, Latthe P, Farquhar C, Khan K, Johnson N. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001896. DOI: 10.1002/14651858.CD001896.pub2.

32. Bourdel N, Alves J, Pickering G, Ramilo I, Roman H, Canis M. Systematic review of endometriosis pain assessment: how to choose a scale? Hum Reprod Update 2015;21:136–52.

33. Hanghoj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health 2014;54:121–38.

34. Allen LM, Lam ACN. Premenstrual syndrome and dysmenorrhea in adolescents. Adolesc Med State Art Rev 2012;23:139–63.

35. Eskenazi B, Warner M, Bonsignore L, Olive D, Samuels S, Vercellini P. Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril 2001;76:929–35.

36. Stratton P, Winkel C, Premkumar A, Chow C, Wilson J, Hearns-Stokes R, et al. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril 2003;79: 1078–85.

37. Dietrich JE, Millar DM, Quint EH. Obstructive reproductive tract anomalies. J Pediatr Adolesc Gynecol 2014;27: 396–402.

38. Silveira SA, Laufer MR. Persistence of endometriosis after correction of an obstructed reproductive tract anomaly. J Pediatr Adolesc Gynecol 2013;26:e93–4.

39. Malinak LR, Buttram VC, Elias S, Simpson JL. Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. Am J Obstet Gynecol 1980;137: 332–7.

40. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817–21.

41. Seo J, Lee D, Yoon B, Choi D. The efficacy of postoperative cyclic oral contraceptives after gonadotropinreleasing hormone agonist therapy to prevent endometrioma recurrence in adolescents. J Pediatr Adolesc Gynecol 2017;30:223–7.

42. Audebert A, Lecointre L, Afors K, Koch A, Wattiez A, Akladios C. Adolescent endometriosis: report of a series of 55 cases with a focus on clinical presentation and long-term issues. J Minim Invasive Gynecol 2015;22:834–40.

43. Fedele L, Parazzini F, Bianchi S, Arcaini L, Candiani GB. Stage and localization of pelvic endometriosis and pain. Fertil Steril 1990;53:155–8.

44. Bayer LL, Hillard PJ. Use of levonorgestrel intrauterine system for medical indications in adolescents. J Adolesc Health 2013;52:S54–8.

45. Unger CA, Laufer MR. Progression of endometriosis in non-medically managed adolescents: a case series. J Pediatr Adolesc Gynecol 2011;24:e21–3.

46. Yoost J, LaJoie AS, Hertweck P, Loveless M. Use of the levonorgestrel intrauterine system in adolescents with endometriosis. J Pediatr Adolesc Gynecol 2013;26: 120–4.

47. Sadler Gallagher J, Feldman HA, Stokes NA, Laufer MR, Hornstein MD, Gordon CM, et al. The effects of gonadotropin-releasing hormone agonist combined with add-back therapy on quality of life for adolescents with endometriosis: a randomized controlled trial. J Pediatr Adolesc Gynecol 2017;30:215–22.

48. DiVasta AD, Feldman HA, Sadler Gallagher J, Stokes NA, Laufer MR, Hornstein MD, et al. Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a randomized controlled trial. Obstet Gynecol 2015;126:617–27.

49. Management of endometriosis. Practice Bulletin No. 114. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:223–36.